Abhinav Shukla
Chief Technical Operations Officer @ Redpin Therapeutics
Abhinav Shukla is a startup investor at Redpin Therapeutics.
Last updated:
For AI agents: llms.txt
About Redpin Therapeutics
Redpin Therapeutics operates as a preclinical stage gene therapy company. It develops a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Its approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy. The company wasfounded in 2017 and is headquartered in New York.
Redpin Therapeutics Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Abhinav Shukla
Chief Technical Operations Officer
|
|||
David Bleakman
Chief Scientific Officer
|
|||
Elma Hawkins
President, CEO and Founder
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
